LYKALABS

Lyka Labs Share Price Lyka Labs

₹128.2
-0.6 (-0.47%)
25 April, 2024 06:35 BSE: 500259 NSE: LYKALABSISIN: INE933A01014

Start SIP in Lyka Labs

Start SIP

Lyka Labs Performance

Day Range

  • Low 127
  • High 132
₹ 128

52 Week Range

  • Low 89
  • High 144
₹ 128
  • Open Price130
  • Previous Close129
  • Volume54913

Lyka Labs Share Price

  • Over 1 Month +14.62%
  • Over 3 Month +9.11%
  • Over 6 Month +17.35%
  • Over 1 Year +21.92%

Lyka Labs Key Statistics

P/E Ratio -128
PEG Ratio -1.5
Market Cap Cr 424
Price to Book Ratio 9.3
EPS -1.9
Dividend 0
Relative Strength Index 61.44
Money Flow Index 82.13
MACD Signal 2.18
Average True Range 5.6
Lyka Labs Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 31272119
Operating Expenses Qtr Cr 26231917
Operating Profit Qtr Cr 6433
Depreciation Qtr Cr 3333
Interest Qtr Cr 1113
Tax Qtr Cr 1000
Net Profit Qtr Cr 10-2-3
IndicatorMar 2023
Total Revenue Annual Cr 84
Operating Expenses Annual Cr 65
Operating Profit Annual in Cr 16
Depreciation Cr 14
Interest Annual Cr 12
Tax Annual Cr 0
Net Profit Annual Cr -13
IndicatorMar 2023
Cash from Operating Activity Annual Cr 7
Cash from Investing Activity Annual Cr 7
Cash from Financing Annual Activity Cr -20
Net Cash Flow Annual Cr -7
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 78
Fixed Assets Annual Cr 82
Total Non Current Assets Annual Cr 137
Total Current Assets Annual Cr 42
Total Assets Annual Cr 179
IndicatorMar 2023
Book Value Per Share Annual Rs 25
ROE Annual % -17
ROCE Annual % 4
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 24
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 33282322
Operating Expenses Qtr Cr 26242019
Operating Profit Qtr Cr 7433
Depreciation Qtr Cr 3433
Interest Qtr Cr 1113
Tax Qtr Cr 1000
Net Profit Qtr Cr 20-2-3
IndicatorMar 2023
Total Revenue Annual Cr 96
Operating Expenses Annual Cr 76
Operating Profit Annual in Cr 17
Depreciation Cr 14
Interest Annual Cr 12
Tax Annual Cr 0
Net Profit Annual Cr -13
IndicatorMar 2023
Cash from Operating Activity Annual Cr 9
Cash from Investing Activity Annual Cr 7
Cash from Financing Annual Activity Cr -22
Net Cash Flow Annual Cr -5
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 47
Fixed Assets Annual Cr 84
Total Non Current Assets Annual Cr 107
Total Current Assets Annual Cr 44
Total Assets Annual Cr 152
IndicatorMar 2023
Book Value Per Share Annual Rs 15
ROE Annual % -29
ROCE Annual % 5
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 22

Lyka Labs Technicals

EMA & SMA

Current Price
₹128.2
-0.6 (-0.47%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹123.14
  • 50 Day
  • ₹121.27
  • 100 Day
  • ₹120.79
  • 200 Day
  • ₹119.78
  • 20 Day
  • ₹120.61
  • 50 Day
  • ₹120.84
  • 100 Day
  • ₹122.66
  • 200 Day
  • ₹118.47

Lyka Labs Resistance and Support

PIVOT
₹128.94
Resistance
First Resistance 131.07
Second Resistance 133.93
Third Resistance 136.07
RSI 61.44
MFI 82.13
MACD Single Line 2.18
MACD 3.20
Support
First Resistance 126.07
Second Resistance 123.93
Third Resistance 121.07

Lyka Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 64,286 4,207,519 65.45
Week 175,277 7,494,862 42.76
1 Month 140,771 7,498,891 53.27
6 Month 147,296 8,998,287 61.09

Lyka Labs Result Highlights

Lyka Labs Synopsis

NSE-Medical-Generic Drugs

Lyka Labs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 80.59 Cr. and Equity Capital is Rs. 30.69 Cr. for the Year ended 31/03/2023. Lyka Labs Ltd. is a Public Limited Listed company incorporated on 29/12/1976 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1976PLC008738 and registration number is 008738.
Market Cap 424
Sales 99
Shares in Float 1.49
No of funds 16
Yield
Book Value 5.15
U/D Vol ratio 1.5
LTDebt / Equity 82
Alpha 0.01
Beta 0.8

Lyka Labs

Owner NameApr-24Mar-24Dec-23Sep-23
Promoters 58.1%54.81%54.81%54.81%
Mutual Funds 0.01%0.01%0.01%0.01%
Insurance Companies 0.37%0.4%0.4%0.4%
Foreign Portfolio Investors 0.16%0.17%0.17%0.18%
Financial Institutions/ Banks
Individual Investors 31.48%33.91%34.32%35.5%
Others 9.88%10.7%10.29%9.1%

Lyka Labs Management

Name Designation
Mr. Babulal Jain Chairman
Mr. Kunal Gandhi Managing Director & CEO
Mr. Yogesh B Shah Executive Director & CFO
Mr. Sandeep P Parikh Independent Director
Mrs. Dhara P Shah Independent Director
Mr. Prashant Godha Non Executive Director
Mr. Shashil Mendosa Non Executive Director

Lyka Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lyka Labs Corporate Action

Date Purpose Remarks
2024-04-16 Others inter alia: to allot and issue 26,00,000 Equity Shares upon conversion of 26,00,000 Warrants to Ipca Laboratories Limited, part of a Promoter Group.
2024-02-08 Quarterly Results
2023-11-02 Quarterly Results
2023-08-02 Quarterly Results
2023-05-23 Audited Results

Lyka Labs MF Shareholding

Name Amount(cr)
Quant Active Fund Growth 8,732

Lyka Labs FAQs

What is Share Price of Lyka Labs ?

Lyka Labs share price is ₹128 As on 25 April, 2024 | 06:21

What is the Market Cap of Lyka Labs ?

The Market Cap of Lyka Labs is ₹424.2 Cr As on 25 April, 2024 | 06:21

What is the P/E ratio of Lyka Labs ?

The P/E ratio of Lyka Labs is -128 As on 25 April, 2024 | 06:21

What is the PB ratio of Lyka Labs ?

The PB ratio of Lyka Labs is 9.3 As on 25 April, 2024 | 06:21

Q2FY23